C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate Director C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science
Cures Within Reach Names CURE ID as 2021 Patient Impact Awardee Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a
May 7, 2021 Pediatric COVID-19 Mitigation Strategies Virtual Workshop Click here for WebEx link On May 7th, 2021, 12:00-1:30 PM Eastern Time (US), the PRO Consortium and Rare Disease Su
Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera
C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
March 20, 2021 Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
April 21, 2021 View Now | RDCA-DAP: Searching, visualizing and exploring data in the RDCA-DAP platform to identify data of interest for advanced analysis When: April 21, 2021, 12 p.m. ET Example Disease: Friedreich’s ataxia Presenters: Amanda Borens, MSc, Executiv
C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
April 15, 2021-April 16, 2021 View Now: 12th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 14–15, 2021 On April 14–15, 2021, the 12th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual f